Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables

BMC Bioinformatics

Volumn 7, Issue , 2006, Pages

  Van Belle, Werner ^a   Ånensen, Nina ^b   Haaland, Ingvild ^b   Bruserud, Øystein ^b,c   Høgda, Kjell Arild ^a   Gjertsen, Bjørn Tore ^b,c  

^a Norut IT   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOID LEUKEMIA; BIOLOGICAL PARAMETER; BIOLOGICAL VARIABLES; CORRELATION ANALYSIS; NORMALIZATION FACTORS; POST-TRANSLATIONAL MODIFICATIONS; TWO-DIMENSIONAL GEL ELECTROPHORESIS;

CORRELATION METHODS; DISEASES; ELECTROPHORESIS; PIXELS; SIGNALING; TWO DIMENSIONAL;

PROTEINS;

ISOPROTEIN; PROTEIN P53; TUMOR MARKER; TUMOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; CELL DIFFERENTIATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOGENETICS; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MALE; MOLECULAR IMAGING; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; ALGORITHM; BIOLOGICAL MODEL; COMPUTER SIMULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LEUKEMIA; METABOLISM; PROCEDURES; PROTEIN PROCESSING; STATISTICS;

ALGORITHMS; COMPUTER SIMULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; STATISTICS AS TOPIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33748296112     PISSN: 14712105     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-7-198     Document Type: Article

References (64)

1. O'Farrell PH: High Resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975, 250(10):4007-21.
2. Gorg A, Weiss W, Dunn M: Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4(12):3665-3685.
3. Celis J, Moreira J, Cabezon T, Gromob P, Friis R, Rank F, Gromova I: Identification of extracellular and intracellular signaling components of the mammary adipose tissue and its interstitial fluid in high risk breast cancer patients: toward dissecting the molecular circuitry of epithelial-adipocyte stromal cell interactions. Mol Cell Proteomics 2005, 4(4):492-522.
4. Boyd R, Adams P, Patel S, Loader J, Berry J, Redpath N, Poyser H, Fletcher G, Burgess N, Stamps A, Hudson L, Smith P, Griffiths M, Willis T, Karran E, Catovsky D, Terrett J, Dyer M: Proteomic Analysis of the cell-surface membrane in chronic lymphocytic leukemia: identification of two novel proteins, BCNIPI and MIG2B. Leukemia 2003, 17(8):1605-1612.
5. Gjertsen BT, Oyan A, Marzolf B, Hovland R, Gausdal G, Doskeland SO, Dimitrov K, Golden A, Kalland K, Hood L, Bruserud Ø: Analysis of acute myelogenous leukemia: preparation of samples for genomic and proteomic analysis. J Hematother Stem Cell Res 2002, 11(3):469-81.
6. Sjoholt G, Ånensen N, Wergeland L, McCormak E, Bruserud Ø, Giertsen BT: Proteomics in acute myelogenous leukemia (AML): methodological strategies and identification of protein targets for novel antileukemic therapy. Current Drug Targets 2005, 6(6):631-646.
7. Schmidt C, Przybylski G, Tietze A, Oettle H, Siegert W, Ludwig W: Acute myeloid and T-cell acute lymphoblastic leukaemia with aberrant antigen expression exhibit similar TCRdelta gene rearrangements. Br J Haemotol 1996, 92(4):929-36.
8. Hanash S: Disease proteomics. Nature 2003, 422(6928):226-32.
9. Conrads T, Zhou M, Petricoin E, Liotta L, Veenstra T: Cancer diagnosis using proteomic patterns. Expert Rev Mol Diagn 2003, 3(4):411-20.
10. Cui J, Wang J, He K, Jin B, Wang H, Li W, Kang L, Hu M, Li H, Yu M, Shen B, Wang G, Zang X: Proteomic analysis of human acute leukemia cells: insight into their classification. Clin Cancer Res 2004, 10(20):6887-96.
11. Garell J: Two-dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines. J Biol Chem 1979, 254(16):7961-7977.
12. Curch S: Advances in two-dimensional gel matching technology. Biochem Soc Trans 2004, 32(Pt 3):511-516.
13. Blose S, Hamburger S: Computer-analyzed high resolution two-dimensional gel electrophoresis: a new window for protein research. Biotechniques 1985, 3:232-236.
14. Horgan G, Glasbey CA: Uses of digital image analysis in electrophoresis. Electrophoresis 1995, 16:298-305.
15. Appel R, Hochstrasser D, Funk M, Vargas J, Pellegrini C, Muller A, Sherrer J: The MELANIE Project: from a biopsy to automatic protein map interpretation by computer. Electrophoresis 1991, 12:722-735.
16. Anindya R, Kwan RL, Yarning H, Marten M, Babu R: Analyzing Two-Dimensional Gel Images. Tech. rep. Department of Mathematics and Statistics, University of Maryland; 2003.
17. Schlags W, Walther M, Masree M, Kratzel M, Noe CR, Lachmann B: Towards validating a method for two-dimensional electrophoresis/silver staining. Electrophoresis 2005, 26:2461-2469.
18. Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties; Blood 1998, 92:2322-33.
19. Gilliland D, CT CJ, Felix C: The Molecular Basis of Leukemia. Hematology (Am Soc Hematol Educ Program) 2004:80-97.
20. Chaladon Y, Schwaller J: Targeting mutated protein tyrosine kinases and their signaling pathways in hematologic malignancies. Haematologica 2005, 90:949-68.
21. Lonning P: Genes causing inherited cancer as beacons to identify the mechanisms of chemoresistance. Trends Mol Med 2004, 10(3):113-118.
22. Bode A, Dong Z: Post-translational modifications of p53 in tumorigenesis. Nat Rev Cancer 2004, 4(10):793-805.
23. Harris S, Levine A: The p53 pathway: positive and negative feedback loops. Oncogene 2005, 24(17):2899-908.
24. Shen D, Real F, DeLeo A, Old L, Marks P, Rifkind R: Protein p53 and inducer-mediated erythroleukemia cell commitment to terminal cell division. Proc Natl Aca Sci USA 1983, 80(19):5919-22.
25. Rizzo M, Zepparoni A, Cristofanelli B, Scardigli R, Crescenzi M, Blandino G, Giuliacci S, Ferrari S, Soddu S, Sacchi A: Wt-p53 action in human leukemia cell lines corresponding to different stages of differentiation. Br J Cancer 1998, 77(9):1429-1438.
26. Gonzalez RC, Woods RE: Digital Image Processing Volume chap 7. 2nd edition. Upper Saddle River, New Jersey 07458: Prentice Hall; 2002:432-438.
27. Veterling WT, Flannery BP: Numerical Recipes in C++ Volume chap 10. 2nd edition. Cambridge University Press; 2002.
28. Irish J, Hovland R, Krutzik P, Perez O, Bruserud Ø, Gjertsen B, Nolan G: Single Cell profiling of potentiated phospho-protein networks in cancer cells. Cell 2004, 118:217-228.
29. Adjei A, Hidalgo M: Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol 2005, 10(23):5386-403.
30. Bourdon J, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas D, Saville M, Lane D: p53 isoforms can regulate p53 transcriptional activity. Genes Dev 2005, 19(18):2122-37.
31. Meek D: Multisite phosphorylation and the integration of stress signals at p53. Cell Signal 1998, 10(3):159-66.
32. Stone R, O'Donnell M, Sekeres M: Acute myeloid leukemia. Hematology (Am Soc Hematol Educ Program) 2004:98-117.
33. Hoelzer D, Gokbuget N, Ottmann O, Pui C, Relling M, Appelbaum F, van Dongen J, Szczepanski T: Acute lymphoblastic leukemia. Hematology (Am Soc Hematol Educ Program) 2002:162-92.
34. Waele MD, Renmans W, Gucht KV, Jochmans K, Schots R, Otten J, Trullemans F, Lacor P, Riet IV: Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts. Eur J Haematol 2001, 66(3):178-87.
35. Sakhinia E, Faranghpour M, Yin JL, Brady G, Hoyland J, Byers R: Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow. Br J Haematol 2005, 130(2):233-48.
36. Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C: Proposal for the recognition of minimally differentiated acute myeloid leukemia (AML-MO). Br J Haematol 1991, 78:325-329.
37. Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C: Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976, 33:451-458.
38. Bullinger L, Dohner K, Beir E, Frohling S, Schlenk R, Tibshirani R, Dohner H, Pollack J: Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004, 16(350):1605-16.
39. Valk P, Verhaak R, Beijen M, Erpelinck C, van Waalwilk, van Doorn S, Khosrovani B, Boer J, Beverloo H, Moorhouse M, van der Spek P, Lowenberg B, Delwel R: Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004, 16(350):1617-28.
40. Soddu S, Blandino G, Citro G, Scardigli R, Piaggio G, Ferber A, Calabretta B, Sacchi A: Wild-type p53 gene expression induces granulocytic differentiation of HL-60 cells. Blood 1994, 83(8):2230-7.
41. Tang P, Wang F: Induction of IW 32 erythroleukemia cell differentiation by p53 is dependent on protein tyrosine phosphatase. Leukemia 2000, 14:1292-1300.
42. Lin T, Chao C, Saito S, Mazur S, Murphy M, Apella E, Xu Y: p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 2005, 7(2):165-171.
43. Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C: 1999 World Health Organization Classification of Neoplastic Diseases of the Hematopietic and Lymphoid Tissues: report on the Clinical Advisory Committee Meeting, Arlie House, Virginia. J Clin Oncol 1997, 17:3835-384.
44. Belle WV, Sjøholt G, Ånensen N, Høgda KA, Gjertsen BT: Adaptive Contrast Enhancement of Two-Dimensional Electrophoretic Gels Facilitates Visualization, Orientation and Alignment. 2006 in press.
45. Wang X, Feng DD: Hybrid Registration for Two-Dimensional Gel Protein Images. Third Asia Pacific Bioinformatics Conference (APBC2005) 2005.
46. Big O Notation [http://en.wikipedia.org/wiki/Big_O_notation]
47. Knuth D: The Art of Computer Programming Volume I chap 1.2.11. 3rd edition. Addison-Wesley, Asymptotic Representations; 1997:107-123.
48. Branco J, Croux C, Filzmoser P, Oliviera M: Robust Canonical Correlations: A Comparative Study. Computational Statistics 2005, 20:203-229.
49. Dehon C, Filzmoser P, Croux C: Data Analysis, Classification, and Related Methods, chap. Robust Methods for Canonical Correlation Analysis 2000:321-326.
50. Stutz J, Cheeseman P: Maximum Entropy and Bayesion Methods Cambridge Kluwer Acedemic Publishers, Dordrecht 1995 chap. Auto-Class - a Bayesian Approach to Classification; 1994.
51. Cheeseman P, Stutz J: Advances in Knowledge Discovery and Data Mining AAAI Press/MIT Press chap. Bayesian Classification (AutoClass): Theory and Results; 1996.
52. Hough P: Methods and Means for Recognizing Complex Patterns. US Patent 3,069,654 1962.
53. Conradsen K, Pedersen J: Analysis of two-dimensional electrophoresis gels. Biometrics 1992, 48:1273-1287.
54. Kenny J, Keeping E: The Standard Deviation and Calculation of the Standard Deviation Volume chop 6.5-6.6. 3rd edition. Princeton NJ; 1962:77-80.
55. Bene M, Catoldi G, Knapp W, Ludwig W, Matutes E, Orfao A, Veer MV: Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia 1995, 9(10):1783-6.
56. Wheatley K, Burnett A, Goldstone A, Gray R, Hann I, Harrison C, Rees J, Stevens R, Walker H: A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties. Br J Haematol 1999, 107:69-79.
57. Øystein Bruserud, Hovland R, Wergeland L, Huang T, Gjertsen BT: FItS-mediated signaling in human acute myelogenous leukemia (AML) blasts: a functional characterization of Flt3-ligand effects in AML cell populations with and without genetic Flt3 abnormalities. Haematologica 2003, 88:416-428.
58. Ersvaer E, Bertelsen L, Espenes L, Bredholt T, Boe S, Iversen B, Øystein Bruserud, Ulvestad E, Gjertsen BT: Characterization of ribosomal P autoantibodies in relation to cell destruction and autoimmune disease. Scan J Immunol 2004, 60(2):189-198.
59. Gjertsen BT, Mellgren G, Otten A, Maronde E, Genieser HG, Jastroff B, Vintermyr O, McKnight GS, Doskeland SO: Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-I β action. J Biol Chem 1995, 270(35):20599-607.
60. Research Systems Inc (RSI) C Boulder: IDL, The Interactive Data Language, v6.1.
61. Blender 3D [http://www.blender3d.org/]
62. Mplayer Headquarters [http://www.mplayerhq.hu/]
63. Winzip - The ZIP Utility for windows [http://www.winzip.com/]
64. Ziplt: Macintosh Compression Utility [http://www.maczipit.com/]